Pfizer And BioNTech Get CureVac MRNA Patent Chucked
Pfizer and BioNTech won their bid to scrap two CureVac patents Tuesday, after a London judge held that the gene therapy-related invention was missing key information that would merit protection....To view the full article, register now.
Already a subscriber? Click here to view full article